Evidence map›Paper›PMID 28218361›Full record

ArticleThe journal of vascular access2017

Arteriovenous fistula maturation in patients with permanent access created prior to or after hemodialysis initiation.

Juan C Duque, Laisel Martinez, Marwan Tabbara, Denise Dvorquez, Sushil K Mehandru, Arif Asif, Roberto I Vazquez-Padron, Loay H Salman

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in The journal of vascular access, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03188978 (High-intensity Atorvastatin for Arteriovenous Fistula Failure), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03188978 phase1 / phase2withdrawnnot on this mapstarted 2018, after this paper: background citation

High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study

TypeinterventionalSponsorAlbany Medical CollegeRan2018 to 2019Enrolled0ConditionsPrimary Arteriovenous Fistula FailureArmsAtorvastatin 40mg, Placebo
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An atypical case of hemodialysis access stent migration.Clinical nephrology. Case studies · 2022
    Article
  5. Atorvastatin ReducesJournal of the American Society of Nephrology : JASN · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Juan C DuqueDepartment of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida - USA.
Laisel MartinezDeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida - USA.
Marwan TabbaraDeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida - USA.
Denise DvorquezDepartment of Medicine, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida - USA.
Sushil K MehandruDepartment of Medicine, Division of Nephrology, Jersey Shore University Medical Center, Hackensack-Meridian Seton Hall School of Medicine, Neptune, New York - USA.
Arif AsifDepartment of Medicine, Division of Nephrology, Jersey Shore University Medical Center, Hackensack-Meridian Seton Hall School of Medicine, Neptune, New York - USA.
Roberto I Vazquez-PadronDeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida - USA.
Loay H SalmanDivision of Nephrology, Albany Medical College, Albany, New York - USA.
University of Miami · USJersey Shore University Medical Center · USAlbany Medical Center Hospital · US

Funding

Vascular Progenitor Cells in Arteriovenous Fistula StenosisR01DK098511 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ANDREOPOULOS, FOTIOS MATTHAIOS, SALMAN, LOAY HATEM · 2013 to 2016
$1.5M
NIDDK NIH HHS R01 DK098511
6 · The paper itself

Abstract

introductionMultiple factors and comorbidities have been implicated in the ability of arteriovenous fistulas (AVF) to mature, including vessel anatomy, advanced age, and the presence of coronary artery disease or peripheral vascular disease. However, little is known about the role of uremia on AVF primary failure. In this study, we attempt to evaluate the effect of uremia on AVF maturation by comparing AVF outcomes between pre-dialysis chronic kidney disease (CKD) stage five patients and those who had their AVF created after hemodialysis (HD) initiation.

methodsWe included 612 patients who underwent AVF creation between 2003 and 2015 at the University of Miami Hospital and Jackson Memorial Hospital. Effects of uremia on primary failure were evaluated using univariate statistical comparisons and multivariate logistic regression analyses.

resultsPrimary failure occurred in 28.1% and 26.3% of patients with an AVF created prior to or after HD initiation, respectively (p = 0.73). The time of HD initiation was not associated with AVF maturation in multivariate logistic regression analysis (p = 0.57). In addition, pre-operative blood urea nitrogen (p = 0.78), estimated glomerular filtration rate (p = 0.66), and serum creatinine levels (p = 0.14) were not associated with AVF primary failure in pre-dialysis patients.

conclusionsOur results show that clearance of uremia with regular HD treatments prior to AVF creation does not improve the frequency of vascular access maturation.

Indexed as

Arteriovenous Shunt, SurgicalRenal DialysisAdultAgedChi-Square DistributionFemaleFloridaHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLogistic ModelsMaleMiddle AgedMultivariate AnalysisRenal Insufficiency, ChronicRetrospective StudiesRisk FactorsHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID28218361
PMCPMC10949904
OpenAlexW2588366059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.